AC Immune (ACIU) Divestments (2015 - 2025)

AC Immune (ACIU) has reported Divestments for 11 consecutive years, with $186.3 million the latest figure, recorded in Q3 2025.

• In Q3 2025, Divestments rose 212.21% year-over-year to $186.3 million; the TTM figure through Sep 2025 stood at $22.8 million (up 112.37% YoY), while the FY2016 annual figure was -$114753.9, up 54.77% from the prior year.
• Divestments advanced to $186.3 million in Q3 2025 per ACIU's latest filing, from $29.6 million in the prior quarter.
• Across five years, Divestments topped out at $186.3 million in Q3 2025 and bottomed at -$166.0 million in Q3 2024.
• Historically, Divestments has averaged $2.5 million across 5 years, with a median of -$873786.7 in 2021.
• Annual changes were most pronounced in 2021 — Divestments sank 436.57% — and 2023, when it soared 8013.88%.
• AC Immune's Divestments stood at -$26.9 million in 2021, then slumped by 40.99% to -$37.9 million in 2022, then surged by 222.21% to $46.3 million in 2023, then plunged by 458.75% to -$166.0 million in 2024, then soared by 212.21% to $186.3 million in 2025.
• Business Quant data shows ACIU's Divestments at $186.3 million in Q3 2025, $29.6 million in Q1 2025, and -$166.0 million in Q3 2024.